Literature DB >> 6863297

Methylation of erythrocyte membrane proteins at extracellular and intracellular D-aspartyl sites in vitro. Saturation of intracellular sites in vivo.

C M O'Connor, S Clarke.   

Abstract

A cytosolic protein carboxyl methyltransferase (S-adenosyl-L-methionine:protein O-methyltransferase, E.C. 2.1.1.24) purified from human erythrocytes catalyzes the methylation of erythrocyte membrane proteins in vitro using S-adenosyl-L-[methyl-3H]methionine as the methyl group donor. The principal methyl-accepting proteins have been identified by sodium dodecyl sulfate-gel electrophoresis at pH 2.4 and fluorography as the anion transport protein (band 3), ankyrin (band 2.1), and integral membrane proteins with molecular weights of 45,000, 28,000, and 21,000. Many of the methylation sites associated with intrinsic membrane proteins may reside in their extracellular portions, since these same proteins are methylated when intact cells are used as the substrate. The maximal number of methyl groups transferred in these experiments is approximately 30 pmol/mg of membrane protein, a value which represents less than one methyl group/50 polypeptide chains of any methyl-accepting species. The number of methylation sites associated with the membranes is increased, but not to stoichiometric levels, by prior demethylation of the membranes. The additional sites are associated primarily with bands 2.1 and 4.1, the principal methyl acceptors in vivo, suggesting that most methylation sites are fully modified in vivo. Extracellular methylation sites are not increased by demethylation of membranes. The aspartic acid beta-methyl ester which can be isolated from carboxypeptidase Y digests of [3H]methylated membranes is in the unusual D-stereoconfiguration. Similar results have been obtained with [3H]methylated membranes isolated from intact cells (McFadden, P.N., and Clarke, S. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 2460-2464). It is proposed that the methyltransferase recognizes D-aspartyl residues in proteins and is involved with the metabolism of damaged proteins in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863297

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Protect, repair, destroy or sacrifice: a role of oxidative stress biology in inter-donor variability of blood storage?

Authors:  Angelo D'Alessandro; Kirk C Hansen; Elan Z Eisenmesser; James C Zimring
Journal:  Blood Transfus       Date:  2019-06-06       Impact factor: 3.443

2.  Methylation of calmodulin at carboxylic acid residues in erythrocytes. A non-regulatory covalent modification?

Authors:  L S Brunauer; S Clarke
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

3.  Carboxyl methylation of human erythrocyte band 3 in intact cells. Relation to anion transport activity.

Authors:  L L Lou; S Clarke
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

Review 4.  Protein damage and methylation-mediated repair in the erythrocyte.

Authors:  P Galletti; D Ingrosso; C Manna; G Clemente; V Zappia
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

5.  Automethylation of protein (D-aspartyl/L-isoaspartyl) carboxyl methyltransferase, a response to enzyme aging.

Authors:  J A Lindquist; P N McFadden
Journal:  J Protein Chem       Date:  1994-01

6.  Mammalian brain and erythrocyte carboxyl methyltransferases are similar enzymes that recognize both D-aspartyl and L-isoaspartyl residues in structurally altered protein substrates.

Authors:  C M O'Connor; D W Aswad; S Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  Stoichiometric methylation of calcineurin by protein carboxyl O-methyltransferase and its effects on calmodulin-stimulated phosphatase activity.

Authors:  M L Billingsley; R L Kincaid; W Lovenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Armt1: a phoenix rises from the ashes.

Authors:  Derek Hoelz
Journal:  Oncotarget       Date:  2015-10-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.